The Lifetime Expenditure in People with Keratoconus in Saudi Arabia.
economic burden
keratoconus
keratoconus economic burden questionnaire
lifetime expenditure
Journal
Vision (Basel, Switzerland)
ISSN: 2411-5150
Titre abrégé: Vision (Basel)
Pays: Switzerland
ID NLM: 101733282
Informations de publication
Date de publication:
03 Aug 2023
03 Aug 2023
Historique:
received:
01
03
2023
revised:
10
07
2023
accepted:
23
07
2023
medline:
22
8
2023
pubmed:
22
8
2023
entrez:
22
8
2023
Statut:
epublish
Résumé
This study measured and evaluated the socioeconomic burden of people living with keratoconus in Saudi Arabia. This study employed a cross-sectional design, a Keratoconus Economic Burden Questionnaire, and a convenient sample of 89 keratoconus patients (58.4% male) drawn from multiple regions in Saudi Arabia. It was conducted using online surveys, and the data were analyzed using appropriate quantitative techniques. The mean age and annual income of the participants were 33.24 (SD = 6.82) years and USD 9046.52 (SD = 16,866.48), respectively, with only 37% being employed for wages. Up to 94.4% needed glasses or contact lenses at least once a week, and 73.0% received care from optometrists. The condition forced 45.9% of the respondents to change careers or leisure activities, with a further 51.3% having to take time off work. The mean annual out-of-pocket expenses for buying and maintaining glasses or contact lenses, as well as traveling and accommodation for keratoconus-related treatment were USD 2341.76 (SD = 3053.09), with 48.32 incurring upwards of USD 3240 over the period. The treatment costs increased with disease duration, With a prevalence rate of 1 in 375, progressive debilitation, and the lifetime nature of the disease, keratoconus is a critical public health concern in Saudi Arabia. The resulting visual impairment and discomfort, as well as both direct and indirect economic burdens, have considerable impacts on the patient's quality of life.
Identifiants
pubmed: 37606498
pii: vision7030052
doi: 10.3390/vision7030052
pmc: PMC10443371
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Optom Vis Sci. 2020 Sep;97(9):741-748
pubmed: 32932400
Am J Ophthalmol. 2018 Jan;185:43-47
pubmed: 29103959
PLoS One. 2022 Feb 8;17(2):e0263506
pubmed: 35134078
Eye (Lond). 2021 Mar;35(3):883-891
pubmed: 32494040
Cont Lens Anterior Eye. 2022 Jun;45(3):101518
pubmed: 34772626
Open Ophthalmol J. 2017 Jul 31;11:241-251
pubmed: 28932340
Eye (Lond). 2015 Nov;29(11):1504-11
pubmed: 26315704
Indian J Ophthalmol. 2015 Jan;63(1):46-53
pubmed: 25686063
Ophthalmol Eye Dis. 2016 May 12;8:17-21
pubmed: 27199574
Clin Exp Ophthalmol. 2020 Apr;48(3):287-300
pubmed: 31867844
Cureus. 2020 Dec 6;12(12):e11932
pubmed: 33425513
Am J Ophthalmol. 2011 May;151(5):768-773.e2
pubmed: 21310384
Saudi J Ophthalmol. 2018 Apr-Jun;32(2):114-118
pubmed: 29942179
Can J Ophthalmol. 2013 Jun;48(3):173-8
pubmed: 23769778
J Cataract Refract Surg. 2010 Jan;36(1):110-3
pubmed: 20117713
Int Ophthalmol Clin. 2006 Summer;46(3):91-103
pubmed: 16929227
Int Ophthalmol. 2019 Aug;39(8):1723-1733
pubmed: 30047076
Int J Ophthalmol. 2020 Jul 18;13(7):1124-1131
pubmed: 32685402
Am J Ophthalmol. 2009 Nov;148(5):760-5
pubmed: 19674732
Sci Rep. 2021 Jun 21;11(1):12970
pubmed: 34155238
Surv Ophthalmol. 2015 Sep-Oct;60(5):459-80
pubmed: 26077628
Am J Ophthalmol. 2017 Mar;175:169-172
pubmed: 28039037
Ophthalmology. 2017 Aug;124(8):1108-1119
pubmed: 28457614
J Med Econ. 2021 Jan-Dec;24(1):410-420
pubmed: 33210975
Br J Ophthalmol. 2005 Nov;89(11):1403-6
pubmed: 16234439
Cornea. 2015 Aug;34(8):e22-3
pubmed: 26075462
J Refract Surg. 2006 Oct;22(8):764-71
pubmed: 17061713
Ophthalmol Ther. 2018 Dec;7(2):263-292
pubmed: 30191404
J Family Med Prim Care. 2020 Dec 31;9(12):6153-6157
pubmed: 33681056
Biomed Res Int. 2017;2017:7803029
pubmed: 28251158
Int Ophthalmol. 2022 Oct;42(10):3191-3198
pubmed: 35538254
Br J Ophthalmol. 2018 Oct;102(10):1436-1441
pubmed: 29298777